[1]张一秋,石洪成.99Tcm-甲氧基异丁基异腈SPECT预测肺癌多药耐药及化疗疗效[J].国际放射医学核医学杂志,2008,32(6):329-332.
　ZHANG Yi-qiu,SHI Hong-cheng.Single photon emission computed tomography imaging using 99Tcm-methoxyisobuty-lisonitrile predict the multi-drug resistance and chemotherapy efficacy of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(6):329-332.
点击复制

99Tcm-甲氧基异丁基异腈SPECT预测肺癌多药耐药及化疗疗效(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第6期
页码:
329-332
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Single photon emission computed tomography imaging using 99Tcm-methoxyisobuty-lisonitrile predict the multi-drug resistance and chemotherapy efficacy of lung cancer
作者:
张一秋;  石洪成
200032 上海, 复旦大学附属中山医院核医学科
Author(s):
ZHANG Yi-qiu;  SHI Hong-cheng
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
关键词:
99Tcm-甲氧基异丁基异腈; 体层摄影术; 发射型计算机; 单光子; 肺肿瘤; 抗药性; 多药
Keywords:
Technetium-99m methoxyisobutylisonitrile; Tomography; emission-computed; single-photon; Lungneoplasms; Drug resistance; multipe
摘要:
化疗作为肺癌特别是非小细胞肺癌综合治疗的主要手段之一。肺癌耐药尤其是多药耐药成为化疗失败的重要原因。早期发现多药耐药,选择合适的化疗方案,对于肺癌患者至关重要。肺癌的多药耐药与多药耐药相关蛋白(MRP)在肺癌中表达相关,某些亲脂性抗癌化疗药物和99Tcm-甲氧基异丁基异腈(99Tcm-MIBI)可能同为某些MRP的底物,它们在肿瘤细胞中的滞留与MRP的表达相关。因而行无创性的肺99Tcm-MIBI SPECT,在化疗前预测体内MRP的表达或在化疗过程中监测MRP表达的变化,有助于预测肺癌多药耐药及化疗疗效。
Abstract:
Chemotherapy is one of the main comprehensive treatments for lung cancer, especially for non-small cell lung cancer(NSC1C) Multi-drug resistance of lung cancer plays an important role in the failure of chemotherapy. Early detection of multi-drug resistance(MDR) is essential for choosing a suitable chemotherapy regimen for the patients of lung cancer. In recent years lots of literature reports that MDR of lung cancer is related to many kinds of multi-drug resistance protein(MRP) expression in lung cancer. Some lipophilic chemotherapy drugs and 99Tcm-methoxyisobutylisonitrile (99Tcm-MIBI) may be the same substrate for some MRP. These MHP can transport them out of the tumor cells, then the chemotherapy is invalid or non-radioactive concentration. The retention of 99Tcm-MIBI in tumor cells is correlated with the expression of MRP, thus the prediction of the MRP expression before chemotherapy or monitoring MRP expression changes in the process of chemotherapy by using the noninvasive 99Tcm-MIBI single photon emission computed tomography imaging is helpful to predict the MDR and chemotherapy efficacy of lung cancer.

参考文献/References:

[1] 蔺涛.肿瘤多药耐药的研究进展[J].海南医学,2006,17(12):140-142.
[2] Calatozzolo C,Gelati M,Ciusani E,et al.Expression of drug resistance proteins Pgp,MRP1,MRP3,MRP5 and GST-pi in human glioma[J].J Neurooncol,2005,74(2):113-121.
[3] Hipfner DR,Deeley RG,Cole SP.Structural,mechanistic and clinical aspects of MRP1[J].Biochem Biophys Acta,1999,1461(2):359-376.
[4] Kolberg A,Rosa TC,Puhl MT,et al.Low expression of MRP1/CS-X pump ATP ase in lymphocytes of Walker 256 tumour-bearing rats is associated with cyclopentenone prostaglandin accumulation and cancer immunodeficiency[J].Cell Biochem Funct,2006,24(1);23-39.
[5] Scheper RJ,Broxterman HJ,Scheffcr GL,et al.Overexpression of a M (r)110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance[J],Cancer Res,1993,53(7):1475-1479.
[6] 顾岩,王立红,李国华.非小细胞肺癌的多药耐药[J].中国肿瘤临床与康复,2005,12(2):184-186.
[7] Gao Z,Gao Z,Fields JZ,et al.Co-trausfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells[J],Anticancer Res,1998,18(4C):3073-3076.
[8] 车春莉,霍建民.多药耐药相关蛋白在非小细胞肺癌中共表达的临床意义[J].哈尔滨医科大学学报,2006,40(4):309-311.
[9] Paredes Lario A,Blanco Garcia C,Echenique Elizondo M,et al.Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer[J].Arch de Bronconeumol,2007,43(9):479-484.
[10] 彭忠民,罗静,王潍博,等.耐药相关基因表达对Ⅲ期非小细胞肺癌新辅助化疗的临床预测价值探讨[J].癌症,2004,23(8);963-967.
[11] Berger W,Setinek U,Hollaus P,et al.Multidrug resistance markers P-glycoprotein,multidrug resistance protein 1,and lung resistance protein in non-small cell lung cancer prognostic implications[J],J Cancer Res Clin Oncol,2005,131(6):355-363.
[12] Bouhamyia L,Chantot-Bastaraud S,Zaidi S,et al.ImmunolocaIi-zation and cell expression of lung resistance-related protein (LRP)in normal and tumoral human respiratory cells[J].J Histochem Cytochem,2007,55(8):773-782.
[13] Ikuta K,Takemura K,Sasaki K,et al.Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells[J],Biol Pharm Bull,2005,28(4):707-712.
[14] 徐名金.肿瘤阳性显像剂99m锝-甲氧基异丁基异腈研究进展[J].国际肿瘤学杂志,2006,33(10):753-755.
[15] Duan XY,Wang JS,Liu M,et al.Technetium-99m-hexakis-2-methoxyisobutyl-isonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer[J].Ann Nucl Med,2008,22(1):49-55.
[16] Ak I,Gülbas Z,Ocak S,et al.Tc-99m MIBI SPECT imaging inpatients with lung carcinoma:is it a functional probe of multidrug resistance genes?[J].J Comput Assist Tomogr,2007,31(5):795-799.
[17] Akgun A,Cok G,Karapolat I,et al.Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer[J],Ann Nucl Med,2006,20(4):269-275.
[18] 薛建军,杨爱民,张芬茹,等.原发性肺癌摄取99mTc-MIBl与耐多药蛋白表达的关系[J].中国医学影像技术,2006,22(7):1090-1094.
[19] Dirlik A,Burak Z,Goksel T,et al.The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer[J],Ann Nucl Med,2002,16(2):103-108.
[20] 韩宝惠,廖美琳,王帏雯,等.99mTc-MIBI核素显像对预测肺癌化疗疗效的探讨[J].中国肺癌杂志,2000,3(3):224-225.

相似文献/References:

[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
　Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
　Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
　Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
　Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
　Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
　Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
　Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
　Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]杨波,刘长春,张勇,等.99Tcm-MIBI运动负荷-静息心肌灌注显像对冠心病患者经皮腔内冠状动脉血管成形术的疗效评价[J].国际放射医学核医学杂志,2009,33(1):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
　YANG Bo,LIU Chang-chun,ZHANG Yong,et al.Evaluation of the outcomes of 99Tcm-MIBI stress-rest perfusion imaging in coronary heart disease with percutaneous transluminal coronary angioplasty[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
[12]黄建敏,曲雁,潘莉萍.恶性骨肿瘤多药耐药的99Tcm-MIBI体层显像研究[J].国际放射医学核医学杂志,2005,29(4):169.
　HUANG Jian-min,QU Yan,PAN Li-ping.Research of 99Tcm-MIBI SPECT imaging for assessment of multidrug resistance in Bone tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):169.

备注/Memo

备注/Memo:
收稿日期:2008-08-27。
通讯作者:石洪成(E-mail:shihongcheng@sina.com)
更新日期/Last Update: 1900-01-01